Prosztatarák: vizsgálatok itt: Németország
95 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Berlin, Freiburg im Breisgau, Hamburg, Muenster, Nuertingen, Penzberg
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07287150 · EU 2025-521327-67-00 - 3. fázisTaking peopleStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Where
- Berlin, Bonn, Hamburg, Jena, Lübeck, Muenster, Munich, Schwerin
- Életkor
- 18 év and over
- People
- 1310 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00 - 3. fázisTaking peopleDiagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
- Where
- Dresden, Düsseldorf, Gronau, Hamburg, Leipzig, München, Münster, Rostock
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- ABX advanced biochemical compounds GmbH
See details and how to joinNCT06122584 - 1. fázisTaking peopleA Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Where
- Erlangen, Essen, München
- Életkor
- 18 év and over
- People
- 421 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07114601 · EU 2025-522367-15-00 - 3. fázisTaking peopleA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Brunswick, Duesseldorf, Duisburg, Essen, Frankfurt am Main, Hamburg, Heidelberg, Muenster, Munich, Nuertingen, Nuremberg
- Életkor
- 18 év and over
- People
- 1203 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07164443 · EU 2025-520927-26-00 - 3. fázisTaking peopleA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Dresden, Duisburg, Essen, Hamburg, Munich, Nuertingen
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07225946 · EU 2025-522713-29-00 - No phaseNot yet taking people in NémetországAssessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate
- Where
- Berlin, München
- People
- 50 worldwide
- Run by
- Aristotle University Of Thessaloniki
See details and how to joinNCT07888322 - 3. fázisTaking peopleA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
- Where
- Hamburg, Muenster, Nuertingen, Tuebingen
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Pfizer
See details and how to joinNCT06629779 · EU 2024-511652-40-00 - 3. fázisTaking peopleA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Where
- Berlin, Cologne, Duisburg, Frankfurt Am Main, Hamburg, Luebeck, Mainz, Munich, Nuertingen, Nuremberg, Potsdam, Stuttgart
- Életkor
- 18 év and over
- People
- 1440 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00 - 1/2. fázisTaking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Berlin, Deggendorf, Hamburg
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - 1/2. fázisTaking peopleStudy of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Where
- Essen, Jena
- Életkor
- 18 év and over
- People
- 205 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07288359 - 1/2. fázisTaking peopleStudy to assess the safety and efficacy of the SpectraCure P18 System
- Where
- Brunswick
- Életkor
- 18 év and over
- People
- 26 worldwide
- Run by
- SpectraCure AB (publ)
See details and how to join2022-502285-24-00 · EU 2022-502285-24-00 - 2. fázisNot yet taking people in NémetországNew diagnostic pathway in primary diagnosis of clinically significant prostate cancer adding PSMA-PET to mpMRI
- Where
- Augsburg, Munich
- Életkor
- 18 év and over
- People
- 150
- Run by
- Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)
See details and how to join2026-527906-19-00 · EU 2026-527906-19-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Frankfurt
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1. fázisTaking peopleA clinical trial to learn about the effects of INR731 alone or with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer
- Where
- Dresden, Wuerzburg
- Életkor
- 18 év and over
- People
- 26 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-524080-20-00 · EU 2025-524080-20-00 - 1. fázisTaking peopleA Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
- Where
- Dresden, Würzburg
- Életkor
- 18 év and over
- People
- 208 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07570979 - 3. fázisTaking peopleAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- Where
- Aachen, Augsburg, Berlin, Bonn, Cologne, Essen, Muenster, Munich, Rostock
- Életkor
- 18 év to 100 év
- People
- 450 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05939414 · EU 2022-502956-29-00 - 3. fázisTaking peopleA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Where
- Bergisch Gladbach, Berlin, Duisburg, Freiburg im Breisgau, Goettingen, Heidelberg, Munich, Nuertingen, Regensburg
- Életkor
- 18 év and over
- People
- 1314 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136650 · EU 2023-504957-11-00 - 3. fázisTaking peopleA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Berlin, Bonn, Dresden, Erlangen, Essen, Hamburg, Heidelberg, Jena, Kiel, Ulm, Würzburg
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- Amgen
See details and how to joinNCT07213674 - No phaseTaking peopleA Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
- Where
- Many Locations
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Bayer
See details and how to joinNCT07344779 - 3. fázisTaking peopleAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Where
- Augsburg, Berlin, Bonn, Cologne, Dresden, Essen, Jena, Karlsruhe, München, Münster, Nuremberg, Rostock, Stuttgart, Tübingen, Würzburg
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07611110 - 1/2. fázisNot yet taking people in NémetországA study of benfo‑oxythiamine added to Pluvicto® in adults with advanced prostate cancer whose disease is stable after two prior Pluvicto® cycles
- Where
- Essen, Muenster, Munich
- Életkor
- 18 év and over
- People
- 48
- Run by
- Benfovir AG
See details and how to join2026-527059-25-00 · EU 2026-527059-25-00 - 3. fázisTaking peopleA Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
- Where
- Dresden, Essen, Halle Saale, Hamburg, Magdeburg, München, Nuertingen, Rostock, Ulm, Würzburg
- Életkor
- 18 év and over
- People
- 736 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07365995 · EU 2025-524445-27-00 - 2. fázisNot yet taking people in NémetországA study comparing Pluvicto® plus Standard of Care treatment with ADT and Nubeqa® vs. Standard of Care treatment with ADT and Nubeqa® in Patients with mHSPC
- Where
- Freiburg im Breisgau
- Életkor
- 18 év and over
- People
- 72
- Run by
- Medical Center - University Of Freiburg
See details and how to join2026-525520-20-00 · EU 2026-525520-20-00 - 1/2. fázisTaking peopleA Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
- Where
- Dresden, Essen, München, Stuttgart
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07226986 · EU 2025-521859-23-00